Venrock Adviser, LLC

Position in JBIO — Jade Biosciences, Inc.

CIK 1615982 NEW YORK, NY

Position in JBIO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$71,556,488

+$26,310,374 QoQ

Shares Held

3,220,364

0.0% QoQ

Ownership

5.06%

of shares outstanding

% of Portfolio

2.17%

of 13F equity value

Holder Rank

of 153 holders

Holding Since

Mar 2022

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Venrock Adviser, LLC holds $3,294,790,938 across 31 Biotechnology names. JBIO ranks #9 (2.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	8,493,321	$1,127,318,496
2	ORKA	Oruka Therapeutics, Inc.	4,148,428	$394,805,892
3	ERAS	Erasca, Inc.	17,891,812	$327,777,995
4	SYRE	Spyre Therapeutics, Inc.	2,985,448	$265,048,073
5	DNTH	Dianthus Therapeutics, Inc. /DE/	1,180,000	$115,026,400
6	OCUL	Ocular Therapeutix, Inc	10,346,926	$101,606,813
7	DMRA	Damora Therapeutics, Inc.	3,603,595	$93,729,505
8	SVRA	Savara Inc	14,745,943	$90,835,008

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$71,556,488	3,220,364	0.0%	Shares	Sole	2026-08-14
2026-03-31	$45,246,114	3,220,364	0.0%	Shares	Sole	2026-05-15
2025-12-31	$49,690,216	3,220,364	0.0%	Shares	Sole	2026-02-17
2025-09-30	$27,791,741	3,220,364	0.0%	Shares	Sole	2025-11-14
2025-06-30	$32,171,436	3,220,364	—	Shares	Sole	2025-08-14
2023-03-31 AVTE	—	833,927	+11.5%	Shares	Sole	2023-05-15
2022-12-31 AVTE	—	747,869	-10.3%	Shares	Sole	2023-05-15
2022-09-30 AVTE	—	833,927	+41.2%	Shares	Sole	2023-05-15
2022-06-30 AVTE	—	590,408	+290.9%	Shares	Sole	2023-05-15
2022-03-31 AVTE	—	151,037	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.